A detailed history of New York State Common Retirement Fund transactions in Harvard Bioscience Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 16,842 shares of HBIO stock, worth $38,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,842
Previous 16,842 -0.0%
Holding current value
$38,568
Previous $48,000 6.25%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$2.77 - $4.63 $447,377 - $747,782
-161,508 Reduced 90.56%
16,842 $48,000
Q1 2024

May 07, 2024

BUY
$4.02 - $5.39 $144,277 - $193,447
35,890 Added 25.19%
178,350 $756,000
Q4 2023

Feb 01, 2024

BUY
$4.0 - $5.49 $17,852 - $24,501
4,463 Added 3.23%
142,460 $762,000
Q3 2023

Nov 07, 2023

BUY
$4.0 - $5.82 $8,496 - $12,361
2,124 Added 1.56%
137,997 $593,000
Q2 2023

Aug 07, 2023

BUY
$4.19 - $6.16 $169,317 - $248,925
40,410 Added 42.33%
135,873 $746,000
Q1 2023

May 02, 2023

BUY
$2.45 - $4.22 $44,308 - $76,318
18,085 Added 23.37%
95,463 $401,000
Q4 2022

Jan 30, 2023

BUY
$2.12 - $2.86 $203 - $274
96 Added 0.12%
77,378 $214,000
Q3 2022

Nov 08, 2022

SELL
$2.33 - $3.92 $631 - $1,062
-271 Reduced 0.35%
77,282 $198,000
Q2 2022

Aug 04, 2022

SELL
$3.28 - $6.42 $33,934 - $66,421
-10,346 Reduced 11.77%
77,553 $279,000
Q1 2022

May 05, 2022

BUY
$5.16 - $7.14 $54,721 - $75,719
10,605 Added 13.72%
87,899 $546,000
Q4 2021

Feb 02, 2022

SELL
$6.37 - $8.18 $5,382 - $6,912
-845 Reduced 1.08%
77,294 $545,000
Q3 2021

Nov 02, 2021

BUY
$6.98 - $8.47 $711 - $863
102 Added 0.13%
78,139 $545,000
Q2 2021

Aug 02, 2021

SELL
$5.44 - $8.4 $79,940 - $123,438
-14,695 Reduced 15.85%
78,037 $650,000
Q4 2020

Feb 08, 2021

SELL
$3.0 - $4.5 $4,350 - $6,525
-1,450 Reduced 1.54%
92,732 $398,000
Q3 2020

Nov 05, 2020

SELL
$2.75 - $4.2 $35,750 - $54,600
-13,000 Reduced 12.13%
94,182 $283,000
Q2 2020

Aug 07, 2020

BUY
$2.12 - $3.14 $73,564 - $108,958
34,700 Added 47.87%
107,182 $332,000
Q1 2020

May 06, 2020

BUY
$1.42 - $3.29 $1,136 - $2,632
800 Added 1.12%
72,482 $160,000
Q3 2019

Nov 07, 2019

BUY
$1.59 - $3.47 $15,772 - $34,422
9,920 Added 16.06%
71,682 $220,000
Q2 2019

Aug 09, 2019

SELL
$1.93 - $4.59 $45,586 - $108,415
-23,620 Reduced 27.66%
61,762 $124,000
Q1 2019

May 08, 2019

SELL
$2.77 - $4.38 $12,049 - $19,053
-4,350 Reduced 4.85%
85,382 $368,000
Q4 2018

Feb 08, 2019

SELL
$3.03 - $5.0 $9,241 - $15,250
-3,050 Reduced 3.29%
89,732 $285,000
Q2 2018

Aug 10, 2018

BUY
$4.2 - $5.95 $79,800 - $113,050
19,000 Added 25.75%
92,782 $496,000
Q4 2017

Feb 13, 2018

SELL
$3.08 - $3.8 $36,297 - $44,783
-11,785 Reduced 13.77%
73,782 $243,000
Q3 2017

Nov 06, 2017

BUY
$2.7 - $3.75 $231,030 - $320,876
85,567
85,567 $321,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $95.3M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.